These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 22235382)
1. Systemic arthritis in children: a review of clinical presentation and treatment. Gurion R; Lehman TJ; Moorthy LN Int J Inflam; 2012; 2012():271569. PubMed ID: 22235382 [TBL] [Abstract][Full Text] [Related]
2. Systemic juvenile idiopathic arthritis versus adult-onset Still´s disease: the pertinence of changing the current classification criteria. Silva JR; Brito I Acta Reumatol Port; 2020; 45(2):150-151. PubMed ID: 32895357 [TBL] [Abstract][Full Text] [Related]
3. The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives. Toplak N; Blazina Š; Avčin T Drug Des Devel Ther; 2018; 12():1633-1643. PubMed ID: 29922038 [TBL] [Abstract][Full Text] [Related]
4. The clinical and experimental treatment of Juvenile Idiopathic Arthritis. Nijhuis L; Swart JF; Prakken BJ; van Loosdregt J; Vastert SJ Clin Exp Immunol; 2023 Oct; 213(3):276-287. PubMed ID: 37074076 [TBL] [Abstract][Full Text] [Related]
5. Is Still's Disease an Autoinflammatory Syndrome? Rossi-Semerano L; Koné-Paut I Int J Inflam; 2012; 2012():480373. PubMed ID: 22611516 [TBL] [Abstract][Full Text] [Related]
6. Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives. Ambler WG; Nanda K; Onel KB; Shenoi S Ann Med; 2022 Dec; 54(1):1839-1850. PubMed ID: 35786149 [TBL] [Abstract][Full Text] [Related]
7. The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis. Aljaberi N; Tronconi E; Schulert G; Grom AA; Lovell DJ; Huggins JL; Henrickson M; Brunner HI Pediatr Rheumatol Online J; 2020 Jan; 18(1):7. PubMed ID: 31948488 [TBL] [Abstract][Full Text] [Related]
8. Patients with Systemic Juvenile Idiopathic Arthritis (SJIA) Show Differences in Autoantibody Signatures Based on Disease Activity. Krainer J; Hendling M; Siebenhandl S; Fuehner S; Kessel C; Verweyen E; Vierlinger K; Foell D; Schönthaler S; Weinhäusel A Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759792 [TBL] [Abstract][Full Text] [Related]
10. Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis. Ruperto N; Brunner HI; Ramanan AV; Horneff G; Cuttica R; Henrickson M; Anton J; Boteanu AL; Penades IC; Minden K; Schmeling H; Hufnagel M; Weiss JE; Pardeo M; Nanda K; Roth J; Rubio-Pérez N; Hsu JC; Wimalasundera S; Wells C; Bharucha K; Douglass W; Bao M; Mallalieu NL; Martini A; Lovell D; Benedetti F; Rheumatology (Oxford); 2021 Oct; 60(10):4568-4580. PubMed ID: 33506875 [TBL] [Abstract][Full Text] [Related]
11. Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS). Davies R; Carrasco R; Foster HE; Baildam EM; Chieng SEA; Davidson JE; Ioannou Y; Wedderburn LR; Thomson W; Hyrich KL Semin Arthritis Rheum; 2016 Oct; 46(2):190-195. PubMed ID: 27422803 [TBL] [Abstract][Full Text] [Related]
12. Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis. Chen G; Deutsch GH; Schulert GS; Zheng H; Jang S; Trapnell B; Lee PY; Macaubas C; Ho K; Schneider C; Saper VE; de Jesus AA; Krasnow MA; Grom A; Goldbach-Mansky R; Khatri P; Mellins ED; Canna SW Arthritis Rheumatol; 2022 Jul; 74(7):1271-1283. PubMed ID: 35189047 [TBL] [Abstract][Full Text] [Related]
13. Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease. Brown RA; Henderlight M; Do T; Yasin S; Grom AA; DeLay M; Thornton S; Schulert GS Front Immunol; 2018; 9():2995. PubMed ID: 30619348 [No Abstract] [Full Text] [Related]
14. Clinical profile and juvenile arthritis damage index in children with juvenile idiopathic arthritis: A study from a tertiary care center in south India. Menon NVB; Peethambaran G; Puthiyapurayil AT; Nambudakath C; Arakkal R Int J Rheum Dis; 2018 Apr; 21(4):871-879. PubMed ID: 27309679 [TBL] [Abstract][Full Text] [Related]
15. Systemic Juvenile Idiopathic Arthritis. Lee JJY; Schneider R Pediatr Clin North Am; 2018 Aug; 65(4):691-709. PubMed ID: 30031494 [TBL] [Abstract][Full Text] [Related]
16. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course. Hügle B; Hinze C; Lainka E; Fischer N; Haas JP Pediatr Rheumatol Online J; 2014; 12():28. PubMed ID: 25114627 [TBL] [Abstract][Full Text] [Related]
17. Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapies. Pardeo M; Bracaglia C; De Benedetti F Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):505-516. PubMed ID: 29773270 [TBL] [Abstract][Full Text] [Related]
18. Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management. Kumar S Indian J Pediatr; 2016 Apr; 83(4):322-7. PubMed ID: 26916892 [TBL] [Abstract][Full Text] [Related]